Analyzing the long/short performance of the Equity Analyzer Composite Factors gives insight into both what has been driving US large cap markets and how those drivers have evolved over the course of the year. The results…
US small-cap stocks have underperformed significantly this year. While the S&P 500 price index is up 14.0% year-to-date, the S&P 600 has lost 2.5%. However, this underperformance has not been a straight line down. Small…
The S&P 500's 5.9% rally last week marks the greatest weekly price gain since November 2022. This sharp increase comes after a 10.3% selloff between the start of August and late-October, which put the benchmark in…
South Korean exports are the latest in a series of Asian trade data suggesting that the global trade cycle is bottoming. The 5.1% y/y increase in October marks the first return to growth since September 2022. Among South Korea…
The market has been held hostage by surging rates. Zombie companies are “alive” and are multiplying – they are highly sensitive to surging borrowing costs. Underweight Utilities to reduce portfolio duration. Maintain neutral…
Our Equity Analyzer service is a stock selection platform powered by the BCA Score, a 30-factor stock ranking system. The model tends to benefit from periods of uncertainty due to its high-quality and low volatility tilt. The…
The year-to-date rally in US cyclical stocks has fizzled. After climbing 29% in the first seven months of the year, cyclical equities are down 6.0% since the beginning of August. This drop is happening in the context of a general…
Tech stocks have recently been bearing the brunt of the US equity selloff. The Information Technology and Consumer Discretionary sectors – home to major H1 outperformers including Nvidia, Microsoft, Apple, Amazon, and Tesla…
China’s reopening faltered and now it is applying moderate stimulus. OPEC 2.0’s production discipline is getting results, with oil prices climbing. The Fed will not be able to deliver dovish surprises in Q4 2023. Investors should…
While Chinese stocks have low valuations and are oversold, their attractiveness is dampened by uncertainties in the magnitude of stimulus and the dismal outlook for corporate profits in the next six to nine months.